Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation.
Jian GuXiaozhang XuXiangyu LiLei YueXiaowen ZhuQiuyang ChenJi GaoMaruyama TakashiWenhu ZhaoBo ZhaoYue ZhangMinjie LinJinren ZhouYuan LiangShipeng DaiYufeng PanQing ShaoYu LiYiming WangZibo XuQufei QianTianning HuangXiaofeng QianLing LuPublished in: Oncogene (2024)
The role of tumor-resident microbiota in modulating tumor immunity remains unclear. Here, we discovered an abundance of intra-tumoral bacteria, such us E.coli, residing and resulting in Colorectal cancer liver metastasis (CRLM). E.coli enhanced lactate production, which mediated M2 macrophage polarization by suppressing nuclear factor-κB -gene binding (NF-κB) signaling through retinoic acid-inducible gene 1 (RIG-I) lactylation. Lactylation of RIG-I suppressed recruitment of NF-κB to the Nlrp3 promoter in macrophages, thereby reducing its transcription. This loss of Nlrp3 affected the immunosuppressive activities of regulatory T cells (Tregs) and the antitumor activities of and CD8 + T cells. Small-molecule compound screening identified a RIG-I lactylation inhibitor that suppressed M2 polarization and sensitized CRLM to 5-fluorouracil (5-FU). Our findings suggest that tumor-resident microbiota may be a potential target for preventing and treating CRLM.
Keyphrases
- nuclear factor
- regulatory t cells
- small molecule
- signaling pathway
- patient safety
- toll like receptor
- escherichia coli
- quality improvement
- genome wide
- transcription factor
- dendritic cells
- oxidative stress
- gene expression
- lps induced
- immune response
- cell proliferation
- nlrp inflammasome
- microbial community
- binding protein
- risk assessment
- genome wide identification
- inflammatory response
- anaerobic digestion